Oliver Reinberg analyst KEPLER CHEUVREUX

Currently out of the existing stock ratings of Oliver Reinberg, 1 are a SELL (20%), 3 are a HOLD (60%), 1 are a BUY (20%).

Oliver Reinberg

Work Performance Price Targets & Ratings Chart

Analyst Oliver Reinberg, currently employed at KEPLER CHEUVREUX, carries an average stock price target met ratio of 33.33% that have a potential upside of 4.33% achieved within 10 days.

Oliver Reinberg’s has documented 10 price targets and ratings displayed on 2 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on QGEN, Qiagen NV at 13-Jul-2021.

Wall Street Analyst Oliver Reinberg

Analyst best performing recommendations are on QGEN (QIAGEN NV).
The best stock recommendation documented was for QGEN (QIAGEN NV) at 11/14/2019. The price target of $36.31 was fulfilled within 1 day with a profit of $1.35 (3.86%) receiving and performance score of 38.62.

Average potential price target upside

QGEN Qiagen NV FMS Fresenius Medical Care

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

$53

$4.73 (9.80%)

$55

20 days ago
(01-Oct-2025)

0/2 (0%)

$6.76 (14.62%)

Hold

$50

$1.73 (3.58%)

$48

2 months 15 days ago
(06-Aug-2025)

6/9 (66.67%)

$1.64 (3.39%)

368

Buy

$50

$1.73 (3.58%)

$54

8 months 15 days ago
(06-Feb-2025)

5/9 (55.56%)

$8.87 (21.57%)

282

Hold

$48

$-0.27 (-0.56%)

$49

9 months 16 days ago
(05-Jan-2025)

6/8 (75%)

$4.7 (10.85%)

351

Buy

$50

$1.73 (3.58%)

1 years 3 months 25 days ago
(26-Jun-2024)

2/3 (66.67%)

$10.25 (25.79%)

196

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What Year was the first public recommendation made by Oliver Reinberg?

On 2019

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?